Drug Trial Radar · NCT04559139
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
186
Planned (sponsor's estimate)
Start
Feb 24, 2021
Primary completion
Jul 1, 2028
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Sep 22, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II/III trial compares the effect of adding chemotherapy before and after surgery versus after surgery alone (usual treatment) in treating patients with stage II-III gallbladder cancer. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller; therefore, may reduce the extent of surgery. Additionally, it may make it easier for the surgeon to distinguish between normal and cancerous tissue. Giving chemotherapy after surgery may kill any remaining tumor cells. This study will determine whether giving chemotherapy before surgery increases the length of time before the cancer may return and whether it will increase a patient's life span compared to the usual approach.
Conditions
- Stage II Gallbladder Cancer AJCC v8
- Stage IIA Gallbladder Cancer AJCC v8
- Stage IIB Gallbladder Cancer AJCC v8
- Stage III Gallbladder Cancer AJCC v8
- Stage IIIA Gallbladder Cancer AJCC v8
- Stage IIIB Gallbladder Cancer AJCC v8
Interventions
CisplatinDrug
Given IV
Gemcitabine HydrochlorideDrug
Given IV
LymphadenectomyProcedure
Undergo portal lymphadenectomy
Partial HepatectomyProcedure
Undergo partial hepatectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in overall survivalTime frame: Time from randomization to death or last follow-up, assessed up to 5 years
Locations
367 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Anchorage Associates in Radiation Medicine
Anchorage, Alaska
Anchorage Radiation Therapy Center
Anchorage, Alaska
Alaska Breast Care and Surgery LLC
Anchorage, Alaska
Alaska Oncology and Hematology LLC
Anchorage, Alaska
Alaska Women's Cancer Care
Anchorage, Alaska
Anchorage Oncology Centre
Anchorage, Alaska
Katmai Oncology Group
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Cancer Center at Saint Joseph's
Phoenix, Arizona
Mercy Hospital Fort Smith
Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
CARTI Cancer Center
Little Rock, Arkansas
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mercy Cancer Center - Carmichael
Carmichael, California
Mercy San Juan Medical Center
Carmichael, California
Mercy Cancer Center - Elk Grove
Elk Grove, California
Cedars Sinai Medical Center
Los Angeles, California
Providence Queen of The Valley
Napa, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
Stanford Cancer Institute Palo Alto
Palo Alto, California
Mercy Cancer Center - Rocklin
Rocklin, California
Mercy Cancer Center - Sacramento
Sacramento, California
University of California Davis Comprehensive Cancer Center
Sacramento, California
Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California
Mission Hope Medical Oncology - Santa Maria
Santa Maria, California
Providence Medical Foundation - Santa Rosa
Santa Rosa, California
Providence Santa Rosa Memorial Hospital
Santa Rosa, California
Torrance Memorial Physician Network - Cancer Care
Torrance, California
Torrance Memorial Medical Center
Torrance, California
Woodland Memorial Hospital
Woodland, California
Penrose-Saint Francis Healthcare
Colorado Springs, Colorado
Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado
Saint Francis Cancer Center
Colorado Springs, Colorado
Porter Adventist Hospital
Denver, Colorado
Mercy Medical Center
Durango, Colorado
Southwest Oncology PC
Durango, Colorado
Showing 40 of 367 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.